BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25673120)

  • 21. Laryngeal muscle activity in unilateral vocal fold paralysis patients using electromyography and coronal reconstructed images.
    Sanuki T; Yumoto E; Nishimoto K; Minoda R
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):625-30. PubMed ID: 24493787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormalities in long latency responses to superior laryngeal nerve stimulation in adductor spasmodic dysphonia.
    Ludlow CL; Schulz GM; Yamashita T; Deleyiannis FW
    Ann Otol Rhinol Laryngol; 1995 Dec; 104(12):928-35. PubMed ID: 7492063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Spasmodic Dysphonia].
    Tokashiki R
    Brain Nerve; 2023 Jan; 75(1):15-22. PubMed ID: 36574969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vocal fold paresis: clinical and electrophysiologic features in a tertiary laryngology practice.
    Simpson CB; Cheung EJ; Jackson CJ
    J Voice; 2009 May; 23(3):396-8. PubMed ID: 18329845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of laryngeal botulinum toxin dosage to patient age, vitality, and socioeconomic issues.
    Young DL; Halstead LA
    J Voice; 2014 Sep; 28(5):614-7. PubMed ID: 24954039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia.
    Rosow DE; Parikh P; Vivero RJ; Casiano RR; Lundy DS
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1003-6. PubMed ID: 23535709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spasmodic dysphonia: let's look at that again.
    Murry T
    J Voice; 2014 Nov; 28(6):694-9. PubMed ID: 24972536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. False vocal cord botulinum toxin injection for refractory muscle tension dysphonia: Our experience with seven patients.
    Pacheco PC; Karatayli-Ozgursoy S; Best S; Hillel A; Akst L
    Clin Otolaryngol; 2015 Feb; 40(1):60-4. PubMed ID: 25314339
    [No Abstract]   [Full Text] [Related]  

  • 29. Botulinum Toxin Dosing Trends in Spasmodic Dysphonia Over a 20-year Period.
    Namin AW; Christopher KM; Eisenbeis JF
    J Voice; 2017 Jan; 31(1):107-110. PubMed ID: 27005439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Findings of multiple muscle involvement in a study of 214 patients with laryngeal dystonia using fine-wire electromyography.
    Klotz DA; Maronian NC; Waugh PF; Shahinfar A; Robinson L; Hillel AD
    Ann Otol Rhinol Laryngol; 2004 Aug; 113(8):602-12. PubMed ID: 15330138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Laryngeal electromyography-guided hyaluronic acid vocal fold injection for unilateral vocal fold paralysis: a prospective long-term follow-up outcome report.
    Wang CC; Chang MH; Jiang RS; Lai HC; De Virgilio A; Wang CP; Wu SH; Liu SA; Liang KL
    JAMA Otolaryngol Head Neck Surg; 2015 Mar; 141(3):264-71. PubMed ID: 25590517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adductor spasmodic dysphonia: Botulinum toxin a injections or laser thyroarytenoid myoneurectomy? A comparison from the patient perspective.
    Schuering JHC; Heijnen BJ; Sjögren EV; Langeveld APM
    Laryngoscope; 2020 Mar; 130(3):741-746. PubMed ID: 31169922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of supraglottic squeeze in adductor spasmodic dysphonia: a new technique.
    Young N; Blitzer A
    Laryngoscope; 2007 Nov; 117(11):2082-4. PubMed ID: 17828055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of phonosurgical methods of treatment in spasmodic dysphonia].
    Kosztyła-Hojna B; Berger G; Zdrojkowski M
    Pol Merkur Lekarski; 2017 Feb; 42(248):90-92. PubMed ID: 28258685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laryngeal electromyography in dysphonic patients with incomplete glottic closure.
    De Biase NG; Korn GP; Guglielmino G; Pontes P
    Braz J Otorhinolaryngol; 2012 Dec; 78(6):7-14. PubMed ID: 23306561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transoral laser ventricular fold resection and thyroarytenoid myoneurectomy for adductor spasmodic dysphonia: long-term outcome.
    Su CY; Lai CC; Wu PY; Huang HH
    Laryngoscope; 2010 Feb; 120(2):313-8. PubMed ID: 20013850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indirect laryngoscopic approach for injection of botulinum toxin in spasmodic dysphonia.
    Ford CN; Bless DM; Lowery JD
    Otolaryngol Head Neck Surg; 1990 Nov; 103(5 ( Pt 1)):752-8. PubMed ID: 2126097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electromyographic assessment of spasmodic dysphonia patients prior to botulinum toxin injection.
    Rodriquez AA; Ford CN; Bless DM; Harmon RL
    Electromyogr Clin Neurophysiol; 1994; 34(7):403-7. PubMed ID: 7859668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Patterns of spasmodic dysphonia and botulinum toxin injections].
    Xu W; Han DM; Hou LZ; Zhang L; Gao YH; Ye JY; Wang J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Apr; 40(4):253-7. PubMed ID: 16008256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraoperative laryngeal electromyography in children with vocal fold immobility: results of a multicenter longitudinal study.
    Maturo SC; Braun N; Brown DJ; Chong PS; Kerschner JE; Hartnick CJ
    Arch Otolaryngol Head Neck Surg; 2011 Dec; 137(12):1251-7. PubMed ID: 22183907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.